*8 month update* 1st slide was at my worst back in 2020 vs today. 2nd slide is wet hair, 8 months ago vs today. 3rd slide is dry hair, 8 months ago vs today. 4th slide is hairline dry, 8 months ago vs today. I hopped on HIMS fin/min spray 8 months ago. Dermastamp about 1x every 2 weeks. Progress Pictures 5/27/2024
A user shared an 8-month update on hair regrowth using HIMS fin/min spray and dermastamping every two weeks, showing significant improvement. Others commented on their own progress and hopes for similar results.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Growth journey stated in January
User shared hair growth progress since January using treatments like minoxidil, nizoral shampoo, rosemary oil, biotin oil, and derma roller. Others suggested solutions for minoxidil side effects and recommended adding a multivitamin.
community Posted this years ago but still getting questions!
The user successfully treated their hair loss using 1ml of minoxidil twice daily and dermarolling with a 1.5mm dermaroller once a week. They experienced noticeable results only after combining minoxidil with dermarolling, and they have not used finasteride.
community 5 months 0.3% finasteride / 7% minoxidil. Trust the process lol
A user shared their positive experience with hair regrowth using a topical treatment containing 0.3% finasteride, 7% minoxidil, ketoconazole, and biotin. They noticed results after about three months, experienced some initial shedding, and had minor headaches as a side effect.
community Topical Finasteride 2 year update
The user reported significant improvement in hair quality and stability using topical finasteride for two years, without side effects. They later added minoxidil, which may have further enhanced hair quality.
community Please, if you are thinking about starting meds, do it as early as possible
Start hair loss treatments early for best results. Finasteride, Dutasteride, Minoxidil, and microneedling are commonly used, with some users experiencing side effects but often regretting delayed treatment.
Related Research
6 / 6 results
research Discovering New Progenitor Cell Populations through Lineage Tracing and In Vivo Imaging
This review discusses the evolution of lineage-tracing strategies over the past century, emphasizing their role in identifying progenitor cells and resolving debates about cellular origins, with no new results reported.
research Aromatase deficiency in a male patient - Case report and review of the literature.
This case report describes a male patient with aromatase deficiency, revealing that a c.628G>A mutation can lead to varied clinical features, such as low bone mass and normal metabolic profiles.
research Direct-to-consumer telemedicine in primary care settings: A scoping review of contemporary empirical literature
This abstract highlights the urgent need for rigorous research, quality assessment tools, and health economics analyses to integrate DTC telemedicine with traditional primary care for improved healthcare quality and efficiency.
research Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review
This review discusses the substantial impact of alopecia areata on patients' health-related quality of life, highlighting issues such as personality changes, emotional and social difficulties, and a common occurrence of alexithymia, and emphasizes the need for more specific assessment tools.
research Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
In this analysis, safety data from two clinical trials showed that baricitinib for severe alopecia areata had predictable side effects like infections and elevated CPK, with some serious adverse events noted at low incidence rates; no deaths were reported.
research Local Corticosteroids for Alopecia Areata: A Narrative Review
This review discusses the use of topical and intralesional corticosteroids for treating alopecia areata, highlighting their efficacy and safety but noting recurrence and pain as limitations; no new clinical results are reported.